The Society of Interventional Radiology (SIR) submitted comments to CMS regarding the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) proposed rules, saying the rules could have “unintended consequences for access to care, quality.” 

The U.S. Preventive Services Task Force (USPSTF) issues recommendations about “clinical preventive services such as screenings, counseling services, and preventive medications,” and its recommendations for breast cancer screening and colorectal cancer screening have both made headlines in 2016.

The American College of Radiology (ACR) is now a qualified Provider-Led Entity, according to rules set out by the Centers for Medicare and Medicaid Services (CMS). The ACR will now be able to provide appropriate use criteria for radiologists who are ordering tests or managing treatment for Medicare patients. 

The American College of Radiology (ACR) issued a statement saying it supports provisions in a new Senate bill that would extend the current two-year delay in implementation of U.S. Preventive Services Task Force (USPSTF) breast cancer screening recommendations. 

CMS rearranges the hoops in its proposed rule for value-based payment

As radiology transitions to value-based reimbursement, patient data registries stand to play an increasingly important role

Reimbursements for I-123 ioflupane (DaTscan), a radiopharmaceutical used in dopamine transporter imaging to differentiate Parkinson’s disease from essential tremor or normalcy, decreased significantly in the years after gaining FDA approval, according to a study published by the Journal of the American College of Radiology. Should practices expect this to be the pattern for other radiopharmaceuticals in the future?

Connecticut Governor Dannel P. Malloy has signed a bill that requires insurance companies to cover breast tomosynthesis. The bipartisan legislation, H.B. 5233, passed the Connecticut House of Representatives by a vote of 139-3 in April. The Senate then voted unanimously in favor of the bill in early May.